RADIOIMMUNOTHERAPY OF AT-211-LABELED ANTI-FIBROBLAST GROWTH FACTOR RECEPTOR 4 (FGFR4) ANTIBODY IS A PROMISING THERAPY FOR PERITONEAL DISSEMINATION OF GASTRIC CANCER: IN IMMUNOCOMPETENT MICE STUDY

被引：0
|
作者：
Kuge, Komei
Masuda, Hiroki
Du, Wanying
Yasuda, Tomohiko
Sugiyama, Akira
Haba, Hiromitsu
Tatsumi, Toshifumi
Akimitsu, Nobuyoshi
Kumakura, Yoshitaka
Yoshida, Hiroshi
Seto, Yasuyuki
Wada, Youichiro
Nomura, Sachiyo
机构：
来源：
GASTROENTEROLOGY | 2024年 / 166卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Sa1232
引用
收藏
页码：S392 / S392
页数：1
相关论文
共 19 条
  • [1] RADIOIMMUNOTHERAPY OF AT-211-LABELED ANTI-FIBROBLAST GROWTH FACTOR RECEPTOR 4 (FGFR4) ANTIBODY IS A PROMISING TREATMENT FOR PERITONEAL DISSEMINATION OF GASTRIC CANCER: IN IMMUNOCOMPETENT MICE STUDY
    Kuge, Komei
    Masuda, Hiroki
    Du, Wan-Ying
    Yasuda, Tomohiko
    Sugiyama, Akira
    Haba, Hiromitsu
    Tatsumi, Toshifumi
    Akimitsu, Nobuyoshi
    Kumakura, Yoshitaka
    Yoshida, Hiroshi
    Seto, Yasuyuki
    Wada, Youichiro
    Nomura, Sachiyo
    GASTROENTEROLOGY, 2023, 164 (06) : S990 - S991
  • [2] The promising option of At211-labeled anti-FGFR4 antibody on the dissemination of gastric cancer in immunocompetent mice
    Kuge, Komei
    Masuda, Hiroki
    Du, Wanying
    Yasuda, Tomohiko
    Sugiyama, Akira
    Haba, Hiromitsu
    Tatsumi, Toshifumi
    Akimitsu, Nobuyoshi
    Kumakura, Yoshitaka
    Yoshida, Hiroshi
    Seto, Yasuyuki
    Wada, Youichiro
    Nomura, Sachiyo
    CANCER SCIENCE, 2024, 115 : 79 - 79
  • [3] The efficacy of astatine-211-labeled anti-FGFR4 antibody on dissemination of gastric cancer in immunocompetent mice
    Kuge, Komei
    Masuda, Hiroki
    Du, Wanying
    Yasuda, Tomohiko
    Sugiyama, Akira
    Haba, Hiromitsu
    Tatsumi, Toshifumi
    Akimitsu, Nobuyoshi
    Kumakura, Yoshitaka
    Hiroshi
    Yoshida
    Seto, Yasuyuki
    Wada, Youichiro
    Nomura, Sachiyo
    CANCER SCIENCE, 2023, 114 : 122 - 122
  • [4] Rational generation of anti-fibroblast growth factor receptor 2 antibody for gastric cancer therapy
    Lee, Y. C.
    Chang, C. D.
    Lin, T. Y.
    Lo, Y. N.
    Chang, F. L.
    Chiang, C. W.
    Tsai, K. C.
    Pan, S. L.
    Yen, Y.
    NEW BIOTECHNOLOGY, 2018, 44 : S108 - S108
  • [5] In vitro and in vivo characterization of a novel anti-fibroblast growth factor receptor (FGFR) 2 antibody (BAY 1179470) for the treatment of gastric cancer
    Kopitz, Charlotte
    Sommer, Anette
    Hammer, Stefanie
    Harrenga, Axel
    Stelte-Ludwig, Beatrix
    Dittmer, Frank
    Reetz, Frank
    May, Ekkehard
    Zierz, Ruprecht
    Wittemer-Rump, Sabine
    Schatz, Christoph
    Huynh, H. T.
    Ziegelbauer, Karl
    Kreft, Bertolt
    CANCER RESEARCH, 2014, 74 (19)
  • [6] Fibroblast growth factor receptor 4 (FGFR4): a targetable regulator of drug resistance in colorectal cancer
    R C Turkington
    D B Longley
    W L Allen
    L Stevenson
    K McLaughlin
    P D Dunne
    J K Blayney
    M Salto-Tellez
    S Van Schaeybroeck
    P G Johnston
    Cell Death & Disease, 2014, 5 : e1046 - e1046
  • [7] The role of fibroblast growth factor receptor 4 (FGFR4) signaling in anti-EGFR resistance in colon cancer.
    Cho, Sang Hee
    Kim, Jo-Heon
    Hong, Chang-Soo
    Sun, Eun-Gene
    Ryu, Kyung-Hyun
    Hwang, Jun Eul
    Bae, Woo Kyun
    Chung, Ik-Joo
    Bang, Hyun-Jin
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [8] Fibroblast growth factor receptor 4 (FGFR4): a targetable regulator of drug resistance in colorectal cancer
    Turkington, R. C.
    Longley, D. B.
    Allen, W. L.
    Stevenson, L.
    McLaughlin, K.
    Dunne, P. D.
    Blayney, J. K.
    Salto-Tellez, M.
    Van Schaeybroeck, S.
    Johnston, P. G.
    CELL DEATH & DISEASE, 2014, 5 : e1046 - e1046
  • [9] Fibroblast Growth Factor Receptor 4 (FGFR4) Selective Inhibitors as Hepatocellular Carcinoma Therapy: Advances and Prospects
    Lu, Xiaoyun
    Chen, Hao
    Patterson, Adam V.
    Smaill, Jeff B.
    Ding, Ke
    JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (06) : 2905 - 2915
  • [10] Fibroblast growth factor receptor 4 (FGFR4) G388R polymorphism in colorectal cancer
    Heinzle, C.
    Hunjadi, M.
    Erdem, Z.
    Staettner, S.
    Klimpfinger, M.
    Grasl-Kraupp, B.
    Holzmann, K.
    Grusch, M.
    Berger, W.
    Marian, B.
    EJC SUPPLEMENTS, 2010, 8 (07): : 108 - 108
12